Previous randomized trials, such as FIGARO-DKD and FIDELIO-DKD, have demonstrated the cardiovascular and kidney benefits of finerenone in this population, with the pooled FIDELITY analysis confirming its ability to delay CKD progression 4,5,14
Compounded GLP-1 medications are custom-made by specialized pharmacies that take advantage of a special FDA allowance resulting from a severe shortage of the medications
Dual GIP/GLP-1 agonists show promising cardiovascular benefits in early data, with comprehensive outcome trials currently underway
What started as a luxury treatment is slowly becoming a cornerstone of modern metabolic care
In an interview at the HLTH conference in October 2024, Noorian told Endpoints that Empowers revenue historically grew at a rate of about 40% a year, but thanks to GLP-1s, revenue growth had doubled in the past year